Ablin J., Fitzcharles M.A., Buskila D., Shir Y., Sommer C., Hauser W. Treatment of fibromyalgia syndrome recommendations of recent evidence-based interdisciplinary guidelines with special emphasis on complementary and alternative therapies. Evidence-Based Complementary and Alternative Therapies. 2013.
Ablin J.N., Shoenfeld Y., and Buskila D. Fibromyalgia, infection and vaccination: Two more parts in the etiological puzzle. Journal of Autoimmunity. 27 (2006) 145-52.
Afrin L.B., Butterfield J.H., Raithel M., Molderings G.J. Often seen, rarely recognized: Mast cell activation disease – a guide to diagnosis and therapeutic options. Annals of Medicine. 2016; 48(3): 190-201.
Ahmad J., Tagoe C.E. Fibromyalgia and chronic widespread pain in autoimmune thyroid disease. Clin Rheumatol. 2014 Jul; 33(7):885-91.
Albrecht P.J., Hou Q., Argoff C.E., Storey J.R., Wymer J.P., Rice F.L. Excessive peptidergic sensory innervation of cutaneous arteriole-venule shunts (AVS) in the palmar glabrous skin of fibromyalgia patients: Implications for widespread deep tissue pain and fatigue. Pain Med 2013; 14: 895-915.
Albrecht P.J., Rice F.L. Fibromyalgia syndrome pathology and environmental influences on afflictions with medically unexplained symptoms. Rev Environ Health. 2016; 31(2):281-94.
Alfonso M., Duran R., Arufe M.C. Effect of excitatory amino acids on serum TSH and thyroid hormone levels in freely moving rats. Horm Res. 2000; 54(2):78-83.
Amutio A., Franco C., deCarmen Perez-Fuentes M., Gazquez J.J., Mercader I. Mindfulness training for reducing anger, anxiety, and depression in fibromyalgia patients. Front Psychol. 2014; 5:1572.
Ansarin K., Niroomand B., Najafipour F.N., Aghamohammadzadeh N., Niafar M., Shaeifi A., Shoja M.M. End-tidal CO2 levels lower in subclinical and overt hypothyroidism than healthy controls: No relationship to thyroid function tests. Int J Gen Med. 2011; 4:29-33.
Aoki Y., Inokuchi R., Suwa H. Reduced N-acetylaspartate in the hippocampus in patients with fibromyalgia: A meta-analysis. Psychiatry Res. 2013 Sept 30;213(3): 242-8. Abstract.
Arnold L.M., Fan J., Russell I.J., Yunus M.B., Khan M.A., Kushner I., Olson J.M., Ivenger S.K. The fibromyalgia family study: A genome-wide linkage study scan. Arthritis Rheum. 2013 Apr; 65(4):1122-8. ABSTRACT.
Aschbacher K., Adam E.K., Crofford L.J., Kemeny M.E., Demitrack M.A., Ben-Zvi A. Linking disease symptoms and subtypes with personalized systems-based phenotypes: A proof of concept study. Brain, Behavior, and Immunity. 2012; 26: 1047-56.
Atzeni F., Talotta R., Masala I.F., Giacomelli C., Conversano C., Nucera V., Lucchino B., Iannuccelli C., Di Franco M., Bazzichi L. One Year in Review 2019: Fibromyalgia. Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):3-10.
Autonomic dysfunction. http://www.healthline.com/health/autonomic-dysfunction#symptoms2. Accessed April 21, 2017.
Auvinet B., Chaleil D. Identification of subgroups among fibromyalgia patients.Reumatismo. 2012 Sep 28; 64(4):250-60.
Auvinet B., Chaleil D., Cabane J., Dumolard A., Hatron P., Juvin R., Lanteri-Minet M., Mainguy Y., Negre-Pages L., Pillard F., Riviere D., Maugars Y.M. The interest of gait markers in the identification of subgroups among fibromyalgia patients. Musculoskeletal Disorders. 2011: 12(258).
Baio P., Brucato A., Buskila D., Gershwin M.E., Giacomazzi D., Lopez L.R., Luzzati R., Matsuura E., Selmi C., Sarzi-Puttini P., Atzeni F. Autoimmune diseases and infections: controversial issues. Clin Exp Rheumatol. 2008. Jan-Feb;26 (1 Suppl 48):S74-80. Abstract.
Bateman L., Sarzi-Puttini P., Bubridge C.L., Landen J.W., Masters E.T., Bhadra Brown P., Scavone J.M., Emir B., Vissing R.S., Clair A.G., Pauer L.R. Burden of illness in fibromyalgia patients with comorbid depression. Clin Exp Rheumatol. 2016 Mar 10. [Epub ahead of print]. ABSTRACT.
Batista E.D., Andretta A., de Miranda R.C., Nehring J., dos Santos Paiva E., Madalozzo Schieferdecker M.E. Food intake assessment and quality of life in women with fibromyalgia. Rev Bras Reumatol. 2016; 56(2): 105-10.
Bayazit Y.A., Gursoy S., Ozer E., Karakurum G., Madenci E. Neurotologic manifestations of the fibromyalgia syndrome. J of Neurolo Sci. 2002; 196: 77-80.
Bazzichi L., Giannaccini G., Betti L., Fabbrini L., Schmid L., Palego L., Giacomelli C., Rossi A., Giusti L., DeFeo F., Giuliano T., Mascia G., Bombardieri S., Lucacchini A. ATP, calcium, and magnesium levels in platelets of patients with primary fibromyalgia. Clin Biochem. 2008; 41:1084-90.
Bazzichi L., Rossi A., Giuliano T., De Feo F., Giacomelli C., Consense A., Ciapparelli A., Consense A., Ciapparelli A., Consoli G., Dell’Osso L., Bombardieri S. Association between thyroid autoimmunity and fibromyalgic disease severity. Clin Rheumatol. 2007; 26:2115-20.
Bazzichi L., Giannaccini F., Beti L., Italiani P., Fabbrini L., DeFeo F., Giacomelli C., Giuliano T., Rossi A., Uccelli A., Giusti L., Mascia G., Lucacchini A., Bombardieri S. Peripheral benzodiazepine receptors on platelets of fibromyalgic patients. Clin Biochem. 2006; 39: 867-72.
Bazzichi L., Rossi A., Zirafa C., Monzani F., Tognini S., Dardano A., Santini F., Tonacchera M., De Servi M., Giacomelli C., De Feo F., Coveri M., Massimetti F., Bombardieri S. Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia? Rheumatol Int. 2012; 32:335-41.
Bell I.R., Baldwin C.M., Russek L.G., Schwartz G.E., Hardin E.E. Early life stress, negative paternal relationships, and chemical intolerance in middle-aged women: Support for a neural sensitization model. J Womens Health. 1998 Nov; 7(9): 1135-47. ABSTRACT.
Bell I.R., Baldwin C.M., Schwartz G.E. Sensitization studies in chemically intolerant individuals: Implications for individual difference research. Ann NY Acad Sci. 2001 Mar; 933: 38-47. ABSTRACT.
Bennett R.M. Fibrositis: Misnomer for a common rheumatic disorder. West J Med. 1981 May; 134: 405-13.
Bernabucci M., Notartomaso S., Zappulla C., Fazio F., Cannella M., Motolese M., Battaglia G., Bruno V., Gradini R., Nicoletti F. N-Acetyl-cysteine causes analgesia by reinforcing the endogenous activation of type-2 metabotropic glutamate receptors. Mol Pain. 2012 Oct 23; 8:77. ABSTRACT.
Bettoni L., Bonomi F.G., Zani V., Manisco L., Indelicato A., Lanteri P., Banfi G., Lombardi G. Effect of 15 consecutive cryotherapy sessions on the clinical output of fibromyalgia patients. Clin Rheumatol. 2013; 32:1337-45.
Bijur P.E., Silver W., Gallagher E.J. Reliability of the Visual Analog Scale for Measurement of Acute Pain. Academic Emergency Med. 2001; 8(12): 1153-7.
Bird S.B., Dickson E.W. Clinically significant changes in pain along the visual analog scale. Annals of Emergency Med. December 2001; 38(6): 639-43.
Blackburn-Munro G. Hypothalamo-pituitary-adrenal axis dysfunction as a contributory factor to chronic pain and depression. Curr Pain and Headache Rep. 2004; 8: 116-24.
Blanco I., Beritze N., Arguelles M., Carcaba V., Fernandez F., Janciauskiene S., Oikonomopoulou K., de Serres F.J., Fernandez-Bustillo E., Hollenberg M.D. Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. Clin Rheumatol 2010;29: 1403-12.
Blankfield A. Kynurenine pathway pathologies: Do nicotinamide and other pathway co-factors have a therapeutic role in reduction of symptom severity, including chronic fatigue syndrome (CFS) and fibromyalgia (FM). Int J Tryptophan Res. 2013; 6 (Suppl 1): 39-45.
Boccatonda A., Tripaldi R., Davi G., Santilli F. Oxidative stress modulation through habitual physical activity. Curr Pharm Des. 2016; 22(24): 3648-80.
Boissoneault J., Vatthauer K., O’Shea A., Craggs J.G., Robinson M., Staud R., Berry R.B., Perlstein W., Waxenberg L., McCrae C.S. Low-to-moderate alcohol consumption is associated with hippocampal volume in fibromyalgia and insomnia. Behav Sleep Med. 2016 May; 4:1-13. Epub ahead of print. ABSTRACT.
Bokarewa M.I., Erlandsson M.C., Bjersing J., Dehlin M., and Mannerkorpl K. Smoking is Associated with Reduced Leptin and Neuropeptide Y levels and Higher Pain Experience in Patients with Fibromyalgia. Mediators of Inflammation. Volume 2014.
Bondy B., Baghai T.C., Minov C., Schule C., Schwarz M.J., Zwanzger P., Rupprecht R., Moller H.J. Substance P serum levels are increased in major depression: Preliminary results. Biol Psychiatry. 2003; 53: 538-42.
Bortolato B., Berk M., Maes M., McIntyre R.S., Carvalho A.F. Fibromyalgia and bipolar disorder: Emerging epidemiological associations and shared pathophysiology. Cur Mol Med. 2016; 16(2): 119-36. ABSTRACT.
Bosma R.L., Mojarad E.A., Leung L., Pukall C., Staud R., Stroman P.W. FMRI of spinal and supra-spinal correlates of temporal pain summation in fibromyalgia patients. Hum Brain Mapp. 2016 Jan 9. Abstract. [Epub ahead of print.]
Bote M.E., Garcia J.J., Hinchado M.D., Ortega E. An exploratory study of the effect of regular aquatic exercise on the function of neutrophils from women with fibromyalgia: Role of IL-8 and noradrenaline. Brain, Behavior, and Immunity. 2014; 39: 107-12.
Bote M.E., Garcia J.J., Hinchado M.D., Ortega E. Fibromyalgia: Anti-inflammatory and stress responses after acute moderate exercise. PLoS One 2013. Sept 4; 8(9). Abstract.
Bourji K., Gatto M., Cozzi F., Doria A., Punzi L. Rheumatic and autoimmune thyroid disorders: A causal or casual relationship? Autoimmunity Reviews. 2015; 14: 57-63.
Bradley L.A. Pathophysiologic mechanisms of fibromyalgia and its related disorders. J Clin Psychiatry. 2008;69 Suppl 2:6-13. Abstract.
Brooks L., Hadi J., Amber K.T., Weiner M., La Riche C.L., Ference T. Assessing the prevalence of autoimmune, endocrine, gynecologic, and psychiatric comorbidities in an ethnically diverse cohort of female fibromyalgia patients: Does the time from hysterectomy provide a clue? J Pain Res. 2015 Aug 20; 8:561-9. ABSTRACT.
Burke N.N., Finn D.P., McGuire B.E., Roche M. Psychological stress in early life as a predisposing factor for the development of chronic pain: Clinical and preclinical evidence and neurobiological mechanisms. J of Neurosci Res. 2016. Epub ahead of print.
Buskila D., Atzeni F., and Sarzi-Puttini P. Etiology of fibromyalgia: The possible role of infection and vaccination. Autoimmunity Reviews. 8 (2008): 41-3.
Buskila D. and Sarzi-Puttini P. Genetic Aspects of Fibromyalgia Syndrome. Arthritis Research & Therapy (2006); 8:2.
Busse J.W., Kulkarni A.V., Badwall P., Guyatt G.H., and the Medically Unexplained Syndromes Group. Attitudes toward fibromyalgia: A survey of Canadian chiropractic, naturopathic, physical therapy, and occupational therapy students. BMC Comp and Alt Med. 2008; 8:24.
Bywater E.G.L. Comparative therapeutic value of massage with “adrenaline cream” and with another cream in conditions associated with deep pain. Ann Rheum Dis. 1951; 10:359-64.
Cabanero D., Irie T., Celorrio M., Trousdale C., Owens D.M., Virley D., Albrecht P.J., Caterina M.J., Rice F.L., Moron J.A. Identification of an epidermal keratinocyte AMPA glutamate receptor involved in dermatopathies associated with sensory abnormalities. Pain Rep. 2016 Sept; 1(3): e573. ABSTRACT.
Cagnie B., Coppieters I., Denecker S., Six J., Danneels L., Meeus M. Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI. Seminars in Arthritis and Rheum. 2014; 44: 68-75.
Cairns B.E. Influence of pro-algesic foods on chronic pain conditions. Expert Rev Neurother. 2016; 16(4):415-23. ABSTRACT.
Carbonell-Baeza A., Ruiz J.R., Aparicio V.A., Ortega F.B., Munguia-Izquierdo D., Alvarez-Gallardo I.C., Segura-Jimenez V., Camiletti-Moiron D., Romero A., Estevez-Lopez F., Samos B., Casimiro A.J., Sierra A., Latorre P.A., Pulido-Mantos M., Fernia P., Perez-Lopez I.J., Chillon P., Girela-Rejon M.J., Tercedor P., Lucia A., Delgado-Fernandez M. Land- and water-based exercise interventionin women with fibromyalgia: The al-andalus physical activity randomised controlled trial. BMC Musculo Dis. 2012: 13-8.
Carette S., Lefrancois L. Fibrositis and primary hypothyroidism. J Rheumatol. 1988 Sep; 15(9): 1418-21.
Carrillo-de-la-Pena M.T., Trinanes Y., Gonzalez-Villar A., Gomez-Perretta C., Garcia-Larrea L. Filtering out repetitive auditory stimuli in fibromyalgia: A study of P50 sensory gating. Eur J Pain. 2015; 19:576-84.
Castillo-Saavedra L., Gebodh N., Bikson M., Diaz-Cruz C., Brandao R., Coutinho L., Truong D., Datta A., Shani-Hershkovich R., Weiss M., Laufer I., Reches A., Peremen Z., Geva A., Parra L.C., Fregni F. Clinically effective treatment of fibromyalgia pain with high-definition transcranial direct current stimulation: Phase II open-label dose optimization. J of Pain. 2016 Jan; 17(1): 14-26.
Ceko M., Bushnell M.C., Fitzcharles M.A., Schweinhardt P. Fibromyalgia interacts with age to change the brain. NeuroImage: Clinical 3 (2013) 249-260.
Chakravarty S.D., Markenson J.A. Rheumatic manifestations of endocrine disease. Rheumatology. 2013 Jan; (25)1: 37-43.
Chandran A., Schaefer C., Ryan K., Baik R., McNett M., Zlateva G. The comparative economic burden of mild, moderate, and severe fibromyalgia: Results from a retrospective chart review and cross-sectional survey of working-age U.S. adults. J Manag Care Pharm. 2012 Jul-Aug; 18(6):415-28.
Check J.H., Katsoff D., Kaplan H., Liss J., Boimel P. A disorder of sympathomimetic amines leading to increased vascular permeability may be the etiologic factor in various treatment refractory health problems in women. Medical Hypotheses. 2008; 70: 671-77.
Chen C.H., Yang T.Y., Lin C.L., Chen C.S., Lin W.M., Kuo C.N., Lin M.C., Kao C.H. Dry eye syndrome risks in patients with fibromyalgia: A national retrospective cohort study. Medicine (Baltimore). 2016 Jan; 95(4): e2607.
Chinn S., Caldwell W., Gritsenko K. Fibromyalgia pathogenesis and treatment options update. Curr Pain Headache Rep. 2016; 20: 25.
Choi W., Lim M., Kim J.S., Kim D.J., Chung. Impaired pre-attentive auditory processing in fibromyalgia: A mismatch negativity (MMN) study. Clin Neurophys. 2015; 126:1310-8.
Choy E.H. The role of sleep in pain and fibromyalgia. Nat Rev Rheumatol. 2015 Sept; 11(9): 513-20. Abstract.
Ciccone D.S., Chandler H.K., Natelson B.H. Illness trajectories in the chronic fatigue syndrome: A longitudinal study of improvers versus non-improvers. J Nervous and Mental Dis. 2010; 198(7): 486-93.
Cifre I., Sitges C., Fraiman D., Munoz M.A., Balenzuela P., Gonzalez-Roldan A., Martinez-Jauand M., Birbaumer N., Chialvo D.R., Montoya P. Disrupted functional connectivity of the pain network in fibromyalgia. Psychosomatic Medicine. (2012); 74:55-62.
Civelek G.M., Ciftkaya P.O., Karatas M. Evaluation of restless legs syndrome in fibromyalgia syndrome: An analysis of quality of sleep and life. J of Back and Musculo Rehab. 2014; 27: 537-44.
Coaccioli S., Varrassi G., Sabatini C., Marinangeli F., Giuliani M., Puxeddu A. Fibromyalgia: Nosography and therapeutic perspectives. Pain Practice. 2008; 8(3): 190-201.
Cohen H., Neumann L., Glazer Y., Ebstein R.P., Buskila D. The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val(158) met and fibromyalgia. Clin Exp Rheumatol. 2009 Sept-Oct; 27(5 Suppl 56): S51-56.
Cordero M.D., de Miguel M., Carmona-Lopez I., Bonal P., Campa F., Moreno-Fernandez A.M. Oxidative Stress and mitochondrial dysfunction in fibromyalgia. Neuro Endocinol Lett. 2010; 31(2): 169-73. Abstract.
Cort. Lending a hand: A very different approach to fibromyalgia. https://www.healthrising.org/forums/threads/lending-a-hand-a-very-different-approach-to-fibromyalgia.3497/ Accessed August 27, 2017.
Cruz B.A., Catalan-Soares B., Proietti F. Higher prevalence of fibromyalgia in patients infected with human T cell lymphotropic virus type I. J Rheumatol. 2006 Nov;33 (11):2300-3.
Cuatrecasas G., Alegre C., Casanueva F.F. GH/IGF1 axis disturbances in the fibromyalgia syndrome: Is there a rationale for GH treatment? Pituitary. 2014 June; 17(30): 27-83.
Cunningham J.L., Evans M.M., King S.M., Gehin J.M., Louklanova L.L. Opioid tapering in fibromyalgia patients: Experience from an interdisciplinary pain rehabilitation program. Pain Med. 2016. Epub ahead of print.
Da Silva G., Lorenzi-Filho G., Lage L.V. Effects of yoga and the addition of Tui Na in patients with fibromyalgia. J of Alt and Comp Med. 2007; 13(10): 1107-13.
De Andrade S.C., De Carvahlo R.F., Soares A.S., De Abreu Freitas R.P., De Medeiros Guerra L.M., Vilar M.J. Thalassotherapy for fibromyalgia: A randomized controlled trial comparing aquatic exercises in sea water and water pool. Rheumatol Int. 2008 Dec; 29(2): 147-52. ABSTRACT.
De Luca C., Gugliandolo A., Calabro C., Curro M., Ientile R., Raskovic D., Korkina L., Caccamo D. Role of polymorphisms of inducible nitric oxide synthase and endothelial nitric oxide synthase in idiopathic environmental intolerances. Mediators Inflamm. 2015:245308. Abstract.
De Zanette S.A., Vercelino R., Laste G., Rozisky J.S., Schwertner A., Machado C.B., Xavier F., de Souza I.C., Deitos A., Torres I.L., Caumo W. Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: A phase II, randomized, double-dummy, controlled trial. BMC Pharmacol Toxicol. 2014 Jul 23: 15-40. ABSTRACT.
Dellwo A. Too many nerves: New pathology discovered in fibromyalgia.http://chronicfatigue.about.com/b/2013/07/02/too-many-nerves-new-pathology-discovered-in-fibromyalgia.htm. Accessed August 15, 2017.
Deodhar A.A., Fisher R.A., Blacker C.V.R., Woolf A.D. Fluid retention syndrome and fibromyalgia. Br J of Rheum. 1994; 33: 576-82.
Deshpande S., Rivera D.E., Younger J.W., Nandola N.N. A control systems engineering approach for adaptive behavioral interventions: Illustration with a fibromyalgia intervention. TBM. 2014; 4: 275-89.
Desmeules J., Chabert J., Rebsamen M., Rapiti E., Piguet V., Besson M., Dayer P., Cedraschi C. Central pain sensitization, COMT Val158Met polymorphism, and emotional factors in fibromyalgia. J of Pain. 2014 Feb; 15(2): 129-35.
Desmeules J., Piquet V. Besson M., Chabert J., Rapiti E., Rebsamen M., Rossier M.F., Curtin F., Dayer P., Cedraschi C. Psychological distress in fibromyalgia patients: A role for catechol-O-methyl-transferase Val158met polymorphism. Health Psychol. 2012 Mar; 31(2):242-9. ABSTRACT.
Di Franco M., Bazzichi L., Casale F., Sarzi-Puttini P., Atzeni F. Pain in systemic connective tissue diseases. Best Pract Res Clin Rheumatol. 2015 Feb; 29(1): 53-62. ABSTRACT.
Diatchenko L., Fillingim R.B., Smith S.B., Maixner W. The phenotype and genetic signatures of common musculoskeletal pain conditions. Nature Rev. 2013 June; 9:340-50.
Diaz-Piedra C., Guzman M.A., Buela-Casal G., Catena A. The impact of fibromyalgia symptoms on brain morphometry. Brain Imaging Behav. 2015 Nov 28. ABSTRACT.
Dohrenbusch R., Sodhi H., Lamprecht J., Genth E. Fibromyalgia as a disorder of perceptual organization? An analysis of acoustic stimulus processing in patients with widespread pain. Z Rheumatol. 1997 Dec; 56(6):334-41. ABSTRACT.
Dong, H., Zhang X., Qian Y. Mast cells and neuroinflammation. Med Sci Monit Basic Res. 2014; 20: 200–206.
Dos Santos M.F., Holanda-Afonso R.C., Lima R.L., DaSilva A.F., Moura-Neto V. The role of the blood-brain barrier in the development and treatment of migraine and other pain disorders. Frontiers Cell Neurosci. 2014 October; 8(302).
Doss J., Mo H., Carroll R.J., Crofford L.J., Denny J.C. Phenome-wide association study of rheumatoid arthritis subgroups identifies association between seronegative disease and fibromyalgia. Arthritis Rheum. 2016 September. Epub ahead of print.
Drouot X., Nguyen J.P., Peschanski M., Lefaucheur J.P. The analgic efficacy of chronic motor cortex stimulation is related to sensory changes in the painful zone. Brain. 2002; 125: 1660-64.
Drummond P.D., Willox M. Painful effects of auditory startle, forehead cooling and psychological stress in patients with fibromyalgia or rheumatoid arthritis. J of Psychosom Res. 2013; 74: 378-83.
Duntas L.H., Biondi B. The interconnections between obesity, thyroid function, and autoimmunity: The multifold role of leptin. Thyroid. 2013 Jun; 23(6):646-53.
Dumitrescu A.M., Refetoff, S. Impaired sensitivity to thyroid hormone: Defects of transport, metabolism and action. http://www.thyroidmanager.org/chapter/thyroid-hormone-resistance-syndromes/. Accessed June 8, 2016.
Dursan H., Onrat E., Ercan E., Demirdal U.S., Avsar A., Dundar U., Solak O., Toktas H. Heart rate turbulence analysis in female patients with fibromyalgia. Clinic. 2015; 70(4): 296-300.
Eight hormones involved in exercise. https://www.acefitness.org/blog/5593/8-hormones-involved-in-exercise. Accessed March 8, 2017.
Eisinger J., Zakarian H., Pouly E. Plantamura A., Ayavou T. Protein peroxidation, magnesium deficiency and fibromyalgia. Magnes Res. 1996 Dec; 9(4): 313-6. Abstract.
El Miedany Y., El Gaafary M., Youssef S., Ahmed I. Towards tailored patient’s management approach: Integrating the modified 2010 ACR criteria for fibromyalgia in multidimensional patient reported outcome measures questionnaire. Arthritis. 2016. Epub ahead of print.
Ellingson L.D., Stegner A.J., Schwabacher I.J., Koltyn K.F., and Cook D.B. Exercise Strengthens Central Nervous System Modulation of Pain in Fibromyalgia. Brain Sciences. 2016, 6, 8.
Elmas O., Yildiz S., Bilgin S., Demirci S., Comlekci S., Koyuncuoglu H.R., Akkus S., Colak O.H., Koklukaya E., Arslan E., Ozkan O., Bilgin G. Physiological parameters as a tool in teh diagnosis of fibromyalgia syndrome in females: A preliminary study. Life Sci. 2016; 145:51-6.
Enestrom S., Bengtsson A., Frodin T. Dermal IgG deposits and increase of mast cells in patients with fibromyalgia – relevant findings or epiphenomena? Scand J Rheumatol. 1997; 26(4): 308-13.
Fatima G., Das S.K., Mahdi A.A. Oxidative stress and antioxidative parameters and metal ion content in patients with fibromyalgia syndrome: Implications in the pathogenesis of the disease. Clin Exp Theumatol. 2013 Nov-Dec; 31(6 Suppl 79): S128-33. Abstract.
Fatima G., Das S.K., Mahdi A.A. Some oxidative and antioxidative parameters and their relationship with clinical symptoms in women with fibromyalgia syndrome. Int J Rheum Dis. 2015 Jul 14. Abstract.
Fayad N., Andres E., Rojas G., Moreno S., Serrano-Blanco A., Roca M., Garcia-Campayo J. Brain dysfunction in fibromyalgia and somatization disorder using proton magnetic resonance spectroscopy: A controlled study. Acta Psychiatr Scand 2012; 126: 115-25.
Feraco P., Bacci A., Pedrabissi F., Passamonti L., Zampogna G., Pedrabissi F., Malavolta N., Leonardi M. Metabolic abnormalities in pain-processing regions of patients with fibromyalgia: A 3T MR spectroscopy study. Am J Neuroradiol. Oct 2011; 32: 1585-90.
Fernandes G., Jennings F., Cabral M.V., Buosi A.L., Natour J. Swimming improves pain and functional capacity of patients with fibromyalgia: A randomized controlled trial. Archives of Phys Med and Rehab. 2016; 97: 1269-75.
Fibromyalgia is not all in your head, new research confirms. June 2013. http://m.medicalxpress.com/news/2013-06-fibromyalgia.html. Accessed April 3, 2016. See Albrecht et al.
Fibrositis and adrenaline. Brit Med J. 1953 May; 1096-7.
Finan P.H., Zautra A.J., Davis M.C., Lemery-Chalfant K. Genetic influences on the dynamics of pain and affect in fibromyalgia. Health Psychol. 2010 Mar; 29(2): 134-42.
Fischer S., Doerr J.M., Strahler J., Mewes R., and Thieme K. Stress Exacerbates Pain in the Everyday Lives of Women with Fibromyalgia Syndrome – The Role of Cortisol and Alpha-Amylase. Psychoneuroendocrinology 63 (2016) 68-77.
Fitzcharles M.A., Ste-Marie P.A., Goldenberg D.L., Pereira J.X., Abbey S., Choiniere M., Ko G., Moulin D.E., Panopalis P., Proulx J., Shir Y., the National Fibromyalgia Advisory Panel. 2012 Canadian guidelines for the diagnosis and management of fibromyalgia syndrome: Executive summary. Pain Res Manag. 2013 May/June; 18(3): 119-26.
Fitzgerald C.T., Carter L.P. Possible role for glutamic acid decarboxylase in fibromyalgia symptoms: A conceptual model for chronic pain. Medical Hypotheses. 2011; 77:409-15.
Flak J.N., Myers M.G. Jr. CNS mechanisms of leptin action. Mol Endocrinol. 2015: 1232.
Foerster B.R., Nascimento T.D., DeBoer M., Bender M.A., Rice I.C., Truong D.Q., Bikson M., Clauw D.J., Zubieta J.K., Harris R.E., DaSilva A.F. Excitatory and inhibitory brain metabolites as targets of motor cortex transcranial direct current stimulation therapy and predictors of its efficacy in fibromyalgia. Arthritis Rheumatol. 2015 Feb; 67(2):567-81.
Fox R.I., Stern M., Michelson P. Update in Sjogren syndrome. Curr Op in Rheumat. 2000;12:391-8.
Friedman J.M. The function of leptin in nutrition, weight, and physiology. Nutr Rev. 2002 Oct; 60: S1-14.
Gallagher E.J., Liebman M., Bijur P.E. Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Annals of Emergency Medicine. December 2001; 38(6): 633-8.
Garcia-Leiva J.M., Carrasco J.L., Slim M., Calandre E.P. Celiac symptoms in patients with fibromyalgia: A cross-sectional study. Rheumatol Int. 2015 Mar; 35(3): 561-7. ABSTRACT.
Garrison R.L., Breeding P.C. A metabolic basis for fibromyalgia and its related disorders: The possible role of resistance to thyroid hormone. Medical Hypotheses. 2003; 61(2): 182-9.
Gaskin M.E., Greene A.F., Robinson M.E., Geisser M.E. Negative affect and the experience of chronic pain. J Psychosom Res. 1992 Dec; 36(8): 707-13. ABSTRACT.
Geenen R., Janssens E.L., Jacobs J.W.G., van Staveren W.A. Dietary glutamate will not affect pain in fibromyalgia. J Rheumatol. 2004; 31: 785-7.
Geenen R., Jacobs J.W., Bijlsma J.W. Evaluation and management of endocrine dysfunction in fibromyalgia. Rheum Dis Clin North Am. 2002 May; 28-(2): 389-404. ABSTRACT.
Geisser M.E., Glass J.M., Rajcevska L.D., Clauw D.J., Williams D.A., Kilney P.R., Gracely R.H. A psychological study of auditory and pressure sensitivity in patients with fibromyalgia and healthy controls. J of Pain. 2008 May; 9(5): 417-22.
Genc A., Tur B.S., Ayfur Y. K., Oztuna D., Erdogan M.F. Does aerobic exercise affect the hypothalamic-pituitary-adrenal hormonal response in patients with fibromyalgia Syndrome? J Phys Ther Sci. 2015; 27: 2225-31.
Georgin-Lavialle S., Gaillard R., Moura D., Hermine O. Mastocytosis in adulthood and neuropsychiatric disorders. Translational Research. 2016 August; 174:77-85.
Gerdie B., Ernberg M., Mannerkorpi K., Larsson B., Kosek E., Christidis N., Ghafouri B. Increased interstitial concentrations of glutamate and pyruvate in vastus lateralis of women with fibromyalgia syndrome are normalized after an exercise intervention: A case-control study. PLOS ONE. 2016 Oct; 11(10): e0162010. ABSTRACT.
Gesquiere-Dando A., Attarian S., Maues De Paula A., Pouget J., Salort-Campana E. Fibromyalgia-like symptoms associated with irritable bowel syndrome: A challenging diagnosis of late-onset Pompe disease. Muscle Nerve. 2015 Aug; 52(2): 300-4. ABSTRACT.
Ghizal F., Das S.K., Verma N., Mahdi A.A. Evaluating relationship in cytokines level, Fibromyalgia Impact Questionnaire and Body Mass Index in women with fibromyalgia syndrome. J Back Musculoskelet Rehabil. 2016 Jan 25;29(1):145-9. Abstract.
Giovelli R.A., Santos M.C., Serrano E.V., Valim V. Clinical characteristics and biopsy accuracy in suspected cases of Sjogren’s syndrome referred to labial salivary gland biopsy. BMC Musculoskelet Disord. 2015 Feb 15; 16:30. ABSTRACT.
Giske L., Vollestad N.K., Mengshoel A.M., Jensen J., Knardahl S., Roe C. Attenuated adrenergic responses to exercise in women with fibromyalgia – A controlled study. Eur J of Pain. 2008; 12:351-60.
Gloeckner C.D., Smith B.T., Markovitz C.D., Lim H.H. A new concept for noninvasive tinnitus treatment utilizing multimodal pathways. Conf Proc IEEE Eng Med Biol Soc. 2013; 3122-5.
Goes S.M., Leite N., de Souza R.M, Homann D., Osiecki A.C., Stefanello J.M., Rodacki A.L. Gait characteristics of women with fibromyalgia: A premature aging pattern. Rev Bras Reumatol. 2014 Sep-Oct; 54(5):335-41.
Goldenberg D.L., Clauw D.J., Palmer R.E., Clair A.G. Opioid use in fibromyalgia: A cautionary tale. Mayo Clin Proc. 2016 Mar 11. [Epub ahead of print]. ABSTRACT.
Gonzalez B., Baptista T.M., Branco J.C., Novo R.F. Fibromyalgia characterization in a psychosocial approach. Psychol Health Med. 2015; 20 (3):363-8. ABSTRACT.
Goulart L.I., Rodrigues R.N.D., Peres M.F.P. Restless legs syndrome and pain disorders: What’s in common? Curr Pain Headache Rep. 2014; 18:461.
Gowans S.E., deHueck A. Pool exercise for individuals with fibromyalgia. Curr Opin Rheumatol. 2007; 19: 168-73.
Griep E.N., Boersma J.W., de Kloet E.R. Pituitary release of growth hormone and prolactin in the primary fibromyalgia syndrome. J Rheumatol. 1994;21:2125-30.
Gur A., Cevik R., Nas K., Colpan L., Sarac S. Cortisol and hyptothalamic-pituitary-gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones. Arthritis Res Ther. 2004; 6(3):R232-8. Abstract.
Gur A., Cevik R., Sarac A.J., Colpan L., Em S. Hypothalamic-pituitary-gonadal axis and cortisol in young women with primary fibromyalgia: the potential roles of depression, fatigue, and sleep disturbance in the occurrence of hypocortisolism. Ann Rheum Dis. 2004 Nov;63(11). Abstract.
Haas L., Portela L.V., Bohmer A.E., Oses J.P., Lara D.R. Increased plasma levels of brain derived neurotrophic factor (BDNF) in patients with fibromyalgia. Neurochem Res. 2010 May; 35(5):830-4.
Hassett A.L., Clauw D.J., Williams D.A. Premature aging in fibromyalgia. Curr Aging Sci.2015;8(2):178-85. ABSTRACT.
Hassett A.L., Epel E., Clauw D.J., Harris R.E., Harte S.E., Kairys A., Buyske S., Williams D.A. Pain is associated with short leukocyte telomere length in women with fibromyalgia. J. Pain. 2012 Oct; 13(10):969-69. ABSTRACT.
Hassett A.L., Finan P.H. The role of resilience in the clinical management of chronic pain. Curr Pain Headache Rep. 2016; 20:39.
Hauser W., Wolfe F. Diagnosis and diagnostic tests for fibromyalgia (syndrome).Reumatismo. 2012 Sep 28;64(4): 194-205. ABSTRACT.
Hawley D., Cathey M.A. Fighting. Am J of Nursing. 1985 April; 85(4): 404-6.
Heald C.B. An inquiry into the treatment of fibrositis with observations on vascular communications between bone and muscle. Lancet. 1951 Oct; 659-3.
Heffez D.S., Ross R.D., Shade-Zeldow Y., Kostas K., Shah S., Gottschalk R., Elias D.A., Shepard A., Leurgans S.E., Moore C.G. Clinical evidence for cervical myelopathy due to Chiari malformation and spinal stenosis in a non-randomized group of patients with the diagnosis of fibromyalgia. Eur Spine J. 2004; 13: 516-23.
Heffez D.S. “Is Chiari-I malformation associated with fibromyalgia?” Revisited. Neurosurgery. 2011 Aug; 69(2): E507.
Heller U., Becker E.W., Zenner H.P., Berg P.A. Incidence and clinical relevance of antibodies to phospholipids, serotonin and ganglioside in patients with sudden deafness and progressive inner ear hearing loss. HNO. 1998 Jun; 46(6): 583-6.
Hennard J. A protocol and pilot study for managing fibromyalgia with yoga and meditation. Intl J of Yoga Ther. 2011; 21: 109-21.
Heredia-Jimenez J., Latorre-Roman P., Santos-Campos M., Orantes-Gonzalez E., Soto-Hermoso-Soto V.M. Spatio-temporal gait disorder and gait fatigue index in a six-minute walk test in women with fibromyalgia. Clinical Biomechanics. 2016; 33:1-6.
Heredia-Jimenez J., Orantes-Gonzalez E.O., Soto-Hermoso V.M. Variability of gait, bilateral coordination, and asymmetry in women with fibromyalgia. Gait & Posture.2016 (45): 41-44.
Heredia-Jimenez J.M., Soto-Hermoso V.M. Kinematics gait disorder in men with fibromyalgia. Rheumatol Int. 2014 Jan; 34(1): 63-5.
Hirotsu C., Tufik S., Andersen M.L. Interactions between sleep, stress, and metabolism: From physiological to pathological conditions. Sleep Sci. 2015; 8:143-52.
Hollins M., Walters S. Experimental hypervigilance changes the intensity/ unpleasantness ration of pressure sensations: Evidence for the generalized hypervigilance hypothesis. Exp Brain Res. 2016 Jun; 234(6): 1377-84. ABSTRACT.
Holten K. The effect of dietary glutamate on fibromyalgia and irritable bowel symptoms. Clin Exp Rheumatol. 2012 Nov-Dec; 30(6 Suppl 74): 10-7. ABSTRACT.
Holton K. The role of diet in the treatment of fibromyalgia. Editorial. Pain Manag. 2016; (6)4: 317-20.
Hooten W.M., Townsend C.O., Sletten C.D., Bruce B.K., Rome J.D. Treatment outcomes after multidisciplinary pain rehabilitation with analgesic medication withdrawal for patients with fibromyalgia. Pain Medicine. 2007; 8(1): 8-16.
Howell T.H. Treatment of fibrositis with adrenaline, ephedrine, and belladonna creams. Lancet. 1950 Sept; 395-7.
Huijnen I.P.J. Verbunt J.A., Meeus M., Smeets R.J.E.M. Energy expenditure during functional daily life performances in patients with fibromyalgia. Pain Practice.2015;15(8):748-56.
Hwang E., Barkhuizen A. Update on rheumatologic mimics of fibromyalgia. Curr Pain and Headache Reports. 2006; 10:327-32.
Iqbal R., Mughal M.S., Arshad N., Arshad M. Pathophysiology and antioxidant status of patients with fibromyalgia. Rhematol Int. 2011; 31: 149-52.
Is Nerve Damage Affecting the Lungs in Fibromyalgia? June 22, 2016.
https://www.healthrising.org/forums/threads/is-nerve-damage-affecting-the-lungs-in-fibromyalgia.4541/ Accessed June 25, 2016.
Ivanichev G.A., Starosel’tseva N.G. Fibromyalgia (generalized tendomyopathy): Defect of a program of movements and their realization. Zh Nevrol Psikhiatr Im S S Korsakova. 2000; 100(4):54-61. ABSTRACT.
Ji, L.L., Chounghun K., Zhang Y. Exercise-induced hormesis and skeletal muscle health. Free Rad Bio and Med. 2016; 98:113-22.
Johansson G., Risberg J., Rosenhall U., Orndahl G., Svennerholm L., Nystrom S. Cerebral dysfunction in fibromyalgia: Evidence from regional cerebral blood flow measurements, otoneurological tests and cerebrospinal fluid analysis. Acta Psychiatr Scand. 1995 Feb; 91(2): 86-94.
Johnson A.C., Tran L., Greenwood-van Meerveld B. Knockdown of corticotroin-releasing factor in the central amygdala reveres persistent viscerosomatic hyperalgesia. Transl Psychiatry. 2015; 5: e517.
Johnson C. A Fibromyalgia Doctor Steps Out: Dr. Dantini on Antivirals for CFS and FM. http://phoenixrising.me/archives/1599. Accessed March 18, 2016.
Jones K.D., Burckhardt C.S., Deodhar A.A., Perrin N.A., Hanson G.C., Bennett R.M. A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia. Arthritis Rheum. 2008 Feb; 58(2): 612-22.
Jones K.D., Deodhar P., Lorentzen A., Bennett R.M., Deodhar A.A. Growth hormone perturbations in fibromyalgia: A review. Semin Arthritis Rheum. 2007 Jun:36(6): 357-79. Abstract.
Jones M.D., Booth J., Taylor J.L., Berry B.K. Aerobic Training Increases Pain Tolerance in Healthy Individuals. Med Sci. SProts Exerc. (2014) 46:8:1640-7.
Jones M.D., Booth J., Taylor J.L., Barry B.K. Limited association between aerobic fitness and pain in healthy individuals: A cross-sectional study. Pain Med. 2016 Oct; 17(10): 1799-1808. ABSTRACT.
Kadetoff D., Kosek E. Evidence of reduced sympatho-adrenal and hypothalamic-pituitary activity during static muscular work in patients with fibromyalgia. J Rehadil Med. 2010 Sep; 42(8): 765-72.
Kasikcioglu D., Dinler M., Berker E. Reduced tolerance of exercise in fibromyalgia may be a consequence of impaired microcirculation initiated by deficient action of nitric oxide. Med Hypothesis. 2006; 66: 950-2.
Katz D.L., Greene L., Ali A., Faridi Z. The pain of fibromyalgia syndrome is due to muscle hypoperfusion induced by regional vasomotor dysregulation. Med Hypothesis. 2007; 69:517-25.
Katz J.D., Mamyrova G., Guzhva O., Furmark L. Gender bias in diagnosing fibromyalgia. Gender Med. 2010; 7(10): 19-27.
Kayhan F., Kucuk A., Satan Y., Ilgun E., Arslan S., Ilik F. Sexual dysfunction, mood, anxiety, and personality disorders in female patients with fibromyalgia.Neuropsychiatric Disease and Treatment. 2016; 12: 349-55.
Kelly M. The relief of facial pain by procaine (Novocaine) injections. TOC. 1963 June; 11(6): 586-96. ABSTRACT.
Kim S.H. Skin biopsy findings: Implications for the pathophysiology of fibromyalgia. Medical Hypotheses. 2007; 69: 141-44.
Kim H., Kim J., Loggia M.L., Cahalan C., Garcia R.C., Vangel M.G., Wasan A.D., Edwards R.R., Napadow V. Fibromyalgia is characterized by altered frontal and cerebellar structural covariance brain networks. NeuroImage: Clinical 7 (2015): 667-77.
Klein C.P., Sperotto N.D., Maciel I.S., Leite C.E., Souza A.H., Campos M.M. Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice. Neuropharmacology. 2014 Nov; 86:57-66. ABSTRACT.
Kodner C. Common questions about the diagnosis and management of fibromyalgia. Am Family Phys. 2015 April 1; 91(7): 472-8.
Kuchinad A., Schweinhardt P., Seminowicz D.A., Wood P.B., Chizh B.A., Bushnell M.C.Accelerated brain gray matter loss in fibromyalgia patients: Premature aging of the brain? J of Neuroscience, April 2007; 27(15):4004-7.
La Rubia M., Run A., Molina F., Del Moral M.L. Is fibromyalgia-related oxidative stress implicated in the decline of physical and mental health status? Clin Exp Rhematol.2013 Nov-Dec; 31 (6 Suppl 79):S 121-7. Abstract.
Lami M.J., Martinez M.P., Sanchez A.I. Systematic review of psychological treatment in fibromyalgia. Curr Pain Headache Rep. 2013; 17: 345.
Lan C.C., Tseng C.H., Chen J.H., Lan J.L., Wang Y.C., Tsay G.J., Hsu C.Y. Increased risk of a suicide event in patients with primary fibromyalgia and in fibromyalgia patients with concomitant comorbidities. Medicine. 2016; 94:44.
Larson A.A., Pardo J.V., Pasley J.D. Review of overlap between thermoregulation and pain modulation in fibromyalgia. Clin J Pain. 2014 June; 30(6):544-44.
Latorre P.A., Santos M.A., Heredia-Jimenez J.M., Delgado-Fernandez M., Soto V.M., Manas A., Carbonell-Baeza A. Effect of a 24-week physical training programme (in water and on land) on pain, functional capacity, body composition and quality of life in women with fibromyalgia. Clin Exp Rheumatol. 2013 Nov-Dec; 31(6 Suppl) 79:S72-80. ABSTRACT.
Le Goff P. Is fibromyalgia a muscle disorder? Joint Bone Spine. 2006; 73: 239-42.
Leavitt F., Katz R.S. Cross-sectional neurocognitive data do not support a transition from fibrofog to Alzheimer disease in fibromyalgia patients. JCR. 2015 Mar; 21(2): 81-5.
Leavitt F., Katz R.S. Development of the Mental Clutter Scale. Psychol Rep. 2011 Oct; 109(2): 445-52.
Lee Y.H., Choi S.J., Ji J.D., Song G.G. Candidate gene studies of fibromyalgia: A systematic review and meta-analysis. Rheumatol Int. 2012 Feb; 32(2):427-26. ABSTRACT.
Lee Y.H., Kim J.H., Song G.G. Association between the COMT Val158Met polymorphism and fibromyalgia susceptibility and fibromyalgia impact questionnaire score: A meta-analysis. Rheumatol Int. 2015 Jan; 35(1):159-66. ABSTRACT.
Legangneux E., Mora J.J., Spreux-Varoquaux O., Thorin I., Herrou M., Alvado G., Gomeni C. Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome.Rheumatology (Oxford). 2001 Mar; 40(3): 290-6.
Lekander M., Fredrikson M., Wik G. Neuroimmune relations in patients with fibromyalgia: A positron emission tomography study. Neurosci Lett. 2000 Mar 24; 282(3): 193-6. ABSTRACT.
Lesuis N., van Vliet J., Boers N., den Broeder N., Cats H., Hulscher M.E., Verrips A., den Broeder A.A. The value of routine creatinine kinase the thyroid stimulating hormone testing in patients with suspected fibromyalgia: A cross-sectional study. Rheumatoloy (Oxford). 2016 Ma 30. Epub ahead of print. ABSTRACT.
Littlejohn G. Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome. Rheumatology. 2015 Nov; 11: 639-48.
Liu Y., Qian C., Yang M. Treatment patterns associated with ACR-recommended medications in the management of fibromyalgia in the United States. JMCP. 2016 March; (22) 3: 263-71.
Loetsch J., Geisslinger G., Tegeder I. Genetic modulation of the pharmacological treatment of pain. Pharmacology & Therapeutics. 124 (2009):168-84.
Loggia M.L., Berna C., Kim J., Cahalan C.M., Martel M.O., Gollub R.L., Wasan A.D., Napadow V., Edwards R.R. The lateral prefrontal cortex mediates the hyperalgesic effects of negative cognitions in chronic pain patients. J of Pain. 2015 Aug; 16(8): 692-9.
Lowe J.C. Fibromyalgia: A Medical Mystery Solved. January 27, 2007.http://www.thyroiduk.org.uk/tuk/related_conditions/Fibromyalgia-medical-mystery-solved.html. Accessed April 11, 2016.
Lowe J.C. T3-induced recovery from fibromyalgia by a hypothyroid patient resistant to T4 and desiccated thyroid. http://www.thyroidscience.com/cases/lowe.9.6.10/lowe.t3.fms.9.6.10.htm. Accessed May 31, 2016. Originally published in J Myofascial Ther. 1995; 1(4)26-31.
Lowe J.C, Cullum M.E., Graf J.R., Yellin J. Mutations in the c-erbAß1 gene: Do they underlie euthryoid fibromyalgia? Med Hypotheses. 1997; 48: 125-135.
Lowe J.C., Honeyman G., Yellin J. Lower resting metabolic rate and basal body temperature of fibromyalgia patients compared to matched healthy controls. Thyroid Science. 2006; 1(8): 1-18.
Lowe J.C., Yellin J. Inadequate thyroid hormone regulation as the main mechanism of fibromyalgia: A review of the evidence. Thyroid Science. 2008; (3)6: R1-14.
Luciano J.V., D’Amico F., Cerda-Lafont M., Penarrubia-Maria M.T., Knapp M., Cuesta-Vargas A.I., Serrano-Blanco A., Garcia-Campayo J. Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: An economic evalutaion alongside a 6-month randomized controlled trial. Arthritis Research & Therapy. 2014; 16: 451.
Luff A.P. The Harveain lecture on the various forms of fibrositis and their treatment. Brit Med J. 1913 April; 1(2728): 756-60.
Madden V.J., Harvie D.S., Parker R., Jensen K.B., Vlaeyen J.W.S., Moseley G.L., Stanton T.R. Can Pain or Hyperalgesia Be a Classically Conditioned Response in Humans? A Systematic Review and Meta-Analysis. Pain Medicine 2015; 0: 1-18.
Maekawa K., Clark G.T., Kuboki T. Intramuscular hypoperfusion, adrenergic receptors, and chronic muscle pain. J of Pain. 2002; (3)4: 251-60
Main C.J. Pain assessment in context: a state of the science review of the McGill pain questionnaire 40 years on. Pain. 2016 July; 157(7): 1387-99.
Mannerkorpi K., Landin-Wilhelmsen K., Larsson A., Cider A., Arodell O., Bjersing J.L. Acute effects of physical exercise on the serum insulin-like growth factor system in women with fibromyalgia. BMC Musculo Disorders. 2017: 18-37.
Mano T., Sakamoto H., Fujita K., Makino M., Kakizawa H., Nagata M., Kotake M., Hamada M., Uchimura K., Hayakawa N., Hayashi R., Nakai A., Itoh M., Kuzuya H., Nagasaka A. Effects of thyroid hormone on catecholamine and its metabolite concentrations in rat cardiac muscle and cerebral cortex. Thyroid. 1998 Apr; 8(4): 353-8.
Marcovitz C.D., Smith B.T., Gloeckner C.D., Lim H.H. Investigating a neuromodulation treatment for brain disorders using synchronized activation of multimodal pathways. Sci Rep. 2015 March 25; 5:9462.
Mariotti S. Physiology of the hypothalamic-pituitary thyroidal system. http://www.thyroidmanager.org/chapter/physiology-of-the-hypothalamic-pituitary-thyroidal system. Accessed on July 18, 2016.
Martinez M.P., Sanchez A.I., Miro E., Medina A., Lami M.J. The relationship between the fear-avoidance model of pain and personality traits in fibromyalgia patients. J Clin Psychol Med Settings. 2011 Oct.
Martinez-Lavin M. Fibromyalgia: When distress becomes (un)sympathetic pain. Pain Res and Treatment. 2012: 6 pages.
Martins D.F., Siteneski A., Ludtke D.D., Dal-Secco D., Santos A. R.S. High Intensity Swimming Exercise Decreases Glutamate-Induced Nociception by Activation of G-Protein-Coupled Receptors Inhibiting Phosphorylated Protein Kinase A. Mol Neurobiol. Sept 2016. [Epub ahead of print].
McCrae C.S., O’Shea A.M., Boissoneault J., Vatthauer K.E., Robinson M.E., Staud R., Perlstein W.M., Craggs J.G. Fibromyalgia patients have reduced hippocampal volume compared with healthy controls. J of Pain Res. 2015; 8:47-52.
McDermid A.J., Rollman G.B., McCain G.A. Generalized hypervigilance in fibromyalgia: Evidence of perceptual amplification. Pain. 1996 Aug; 66(2-3):133-44. ABSTRACT.
McNett M., Goldenberg D., Schaefer C., Hufstader M., Baik R., Chandran A., Zlateva G.Treatment patterns among physician specialties in the management of fibromyalgia: Results of a cross-sectional study in the United States. Curr Med Res Opin. 2011 Mar; 27(3): 673-83. ABSTRACT.]
Mease P. J. Further strategies for treating fibromyalgia: The role of serotonine and norepinephrine reuptake inhibitors. Am J Med. 2009 Dec; 122(12 Suppl): S44-55. ABSTRACT.
Meeus M., Nijs J., Hermans L. Goubert D., Calders P. The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients; peripheral and central mechanisms as therapeutic targets? Expert Opin Ther Targets. 2013 Sept; 17(9):1081-9. Abstract.
Meggs W.J. Nerogenic switching: A hypothesis for a mechanism for shifting the site of inflammation in allergy and chemical sensitivity. Environ Health Persp. 1995 Jan; 103(1):54-6.
Meiworm L., Jakob E., Walker U.A., Peter H.H., Keul J. Patients with fibromyalgia benefit from aerobic endurance exercise. Clin Rheumatol. 2000; 19(4):253-7.
Merry T.L., Ristow M. Mitohormesis in exercise training. Free Rad Bio and Med. 2016; 98:123-30.
Metyas S.K., Solyman J.S., Arkfeld D.G. Inflammatory fibromyalgia: Is it real? Current Rheumatology Reviews. 2015, 11, 15-17.
Milovanovic M., Nilsson S., Haakara P.I., Post C., Gerdle B. High in vivo platelet activity in female fibromyalgia patients. J Biomedical Sci. 2016; 5:3.
Miro E., Lupianez J., Hita E., Martinez M.P., Sanchez A.I., Buela-Casal G. Attentional deficits in fibromyalgia and its relationships with pain, emotional distress, and sleep dysfunction complaints. Psychol Health. 2011 Jun; 26(6): 765-50.
Mist S.D., Firestone K.A., Jones D.K. Complementary and alternative exercise for fibromyalgia: A meta-analysis. J of Pain Res. 2013; 6: 247-260.
Molderings G.J., Haenisch B., Brettner S., Homann J., Menzen M., Dumoulin F.L., Panse J., Butterfield J., Afrin L.B. Pharmacological treatment options for mast cell activation disease. Nauyn-Schmiedeberg’s Arch Pharmacol. 2016; 389:671-94.
Montoro C.I., Duschek S. Aberrant cerebral blood flow responses during cognition: Implications for the understanding of cognitive deficits in fibromyalgia. Neuropsychology. 2015; 29(2): 173-82.
Montoro C.I., Duschek S., de Guevara C.M., Reyes Del Paso G.A. Patterns of cerebral blood flow modulation during painful stimulation in fibromyalgia: A transcranial Doppler sonography study. Pain Med. 2016 Dec; 12: 2256-67. ABSTRACT.
Morris L.D., Louw Q.A., Grimmer K.A., Meinties E. Targeting pain catastrophization in patients with fibromyalgia using virtual reality exposure therapy: A proof-of-concept study. J Phys Ther Sci. 2015; 27: 3461-7.
Mountjoy P. New studies find causes of fibromyalgia, offer hope of relief. Washington Times. Wednesday December 31, 2014. http://www.washingtontimes.com/news/2014/dec/31/new-studies-find-causes-fibromyalgia-offer-hope-re/?page=all. Accessed April 7, 2016.
Munguia-Izquierdo D., Legaz-Arrese A. Assessment of the effects of aquatic therapy on global symptomatology in patients with fibromyalgia syndrome: A randomized controlled trial. Arch Phys Med Rehabil. 2008 Dec; (89):2250-7.
Nahin R.L., Boineau R., Khalsa P.S., Stussman B.J., Weber W.J. Evidence-based evaluation of complementary health approaches for pain management in the United States. Mayo Clin Proc. 2016; 91(9): 1292-1306.
Nees F., Ruddel H., Mussgay L., Kuehl L.K., Romer S., Schachinger H. Alteration of delay and trace eyeblink conditioning in fibromyalgia patients. Psychosomatic Med. 2010; 72:412-18.
Nijs J., Kosek E., Van Oosterwijck J., Meeus M. Dysfunctional endogenous analgesia during exercise in patients with chronic pain: To exercise or not to exercise? Pain Physician. 2012; 15: ES205-ES213.
Nishioka K. HTLV-I arthropathy and Sjogren syndrome. J Acquir Immune Defic Syndr Hum Retrovirol. 1996; 13 Suppl 1:S57-62.
Nishioka Ke., Hayashi T., Suzuki M., Li Y., Nakayama S., Matsushima T., Usui C., Shibata N., Motoi Y., Tanaka R., Nishioka Ku., Hattori N. Fibromyalgia syndrome and cognitive dysfunction in the elderly: A case series. Int J of Rheuma Dis. 2016; 19: 21-9.
Nisihara R., Marques A.P., Mei A., Skare T. Celiac disease and fibromyalgia: Is there an association? Letter to the editor. Rev Esp Enferm Dig. 2016; 108(2): 107-8.
Nugraha B., Karst M., Engeli S., Gutenbrunner C. Brain-derived neurotrophic factor and exercise in fibromyalgia syndrome patients: A mini review. Rheumatol Int. 2012 Sept; 32(9): 2593-9.
Nurmatov U.B., Rhatigan E., Simons F.E.R., Sheikh A. H1-antihistamines for primary mast cell activation syndromes: A systematic review. Euro J of Allergy and Clin Immuno. 2015; 70: 1052-61.
Okifuji A. and Hare B.D. Management of Fibromyalgia Syndrome: Review of Evidence. Pain Ther (2013) 2:87-104.
Olsson I., Dahl A.A. Personality problems are considerably associated with somatic morbidity and health care utilisation. European Psychiatry. 2009; 24:442-9.
Ortancil O., Sanli A., Eryksel R., Basaran A., Ankarali H. Association between serum ferritin level and fibromyalgia syndrome. Eur J Clin Nutr. 2010 March; 64(3): 308-12. Abstract.
Ortega E. The “bioregulatory effect of exercise” on the innate/inflammatory responses. J Physiol Biochem. 2016; 72:361-9.
Ozgocmen S., Ozyurt H., Sogut S., Akyol O., Ardicoglu O., Yildizhan H. Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: Etiologic and therapeutic concerns. Rheumatol Int. (2006) 26: 598-603.
Palagini L., Carmassi C., Conversano C., Gesi C., Bazzichi L., Giacomelli C., Dell’Osso L. Transdiagnostic factors across fibromyalgia and mental disorders: Sleep disturbances may play a key role. A clinical review. Clin Exp Rheumatol. 2016 Mar-Apr; 43 (2 Suppl 96): S140-4. ABSTRACT.
Pamuk O.N., Cakir N. The frequency of thyroid entibodies in fibromyalgia patients and their relationship with symptoms. Clin Rheumatol. 2007 Jan; 26(10): 55-9. ABSTRACT.
Park B., Palomares J.A., Woo M.A., Kang D.W., Macey P.M., Yan-Go F.L., Harper R.M., Kumar R. Aberrant insular functional network integrity in patients with obstructive sleep apnea. Sleep. 2016 Jan 15. ABSTRACT.
Park D.J., Kang J.H., Yim Y.R., Kim J.E., Lee J.W., Lee K.E., Wen L., Kim T.J., Park Y.W., Lee S.S. Exploring genetic susceptibility to fibromyalgia. Chonnam Med J. 2015; 51:58-65.
Patel S.H., Azzam P.N. Characterization of N200 and P300: Selected studies of the event-related potential. Int J Med Sci. 2005;2: 147-54.
Pellegrino M.J., Waylonis G.W., Sommer A. Familial occurrence of primary fibromyalgia. Arch Phys Med Rehabil. 1989 Jan; 70(1):61-3. ABSTRACT.
Peppin J.F., Albrecht P.J., Argoff C., Gustorf B., Pappagallo M., Rice F.L., Wallace M.S. Skin matters: A review of tpical treatments for chronic pain. Part One: Skin physiology and delivery systems. Pain Ther. 2015; 4:17-32.
Peppin J.F., Albrecht P.J., Argoff C., Gustorf B., Pappagallo M., Rice F.L., Wallace M.S. Skin matters: A review of tpical treatments for chronic pain. Part Two: Treatments and applications. Pain Ther. 2015; 4:33-50.
Pereira A., Gitlin M.J., Gross R.A., Posner K., Dworkin R.H. Suicidality associated with anti-epileptic drugs: Implications for the treatment of neuropathic pain and fibromyalgia. Pain. 2013 March; 154(3): 345-9.
Pereira J.C., Pradella-Hallinan M., de Lins Pessoa H. Imbalance between thyroid hormones and the dopaminergic system might be central to the pathophysiology of restless legs syndrome: A hypothesis. Clinics. 2010; 65(5): 547-54.
Pingitore A., Pereira Lima G.P., Mastorci F., Quinones A., Iervasi G., Vassalle C. Exercise and oxidative stress: Potential effects of antioxidant dietary strategies in sports. Nutrition. 2015; 31:916-22.
Pridgen W., Duffy C., Gendreau J., and Gendreau R.M. A combination of celecoxib and famciclovir is efficacious in the treatment of fibromyalgia: Results of a phase IIa randomized, double-blind, placebo-controlled study. Abstract number 1878. ACR abstracts. http://acrabstracts.org/abstract. Accessed March 18, 2016.
Puente C.P., Furlong L.V., Gallardo C.E., Mendez M.C., Cruz D.B., de las Penas C.F. Self-efficacy and affect as mediators between pain dimensions and emotional symptoms and functional limitation in women with fibromyalgia. Pain Management Nursing. 2015 Feb; 16(1):60-8.
Puiu T., Kairys A.E., Pauer L., Schmidt-Wilke T., Ichesco E., Hampson J.P., Napadow V., Clauw D.J., Harris R.E. Alterations in gray matter volume are associated with reduced evoked-pain connectivity following acute pregabalin administration. Arthritis Rheumatol. 2016 Jan 27. [Epub ahead of print]. ABSTRACT.
Questions and answers about fibromyalgia. July 2014.http://www.niams.nih.gov/health_info/fibromyalgia/. Accessed April 3, 2016.
Raak R., Wahren L.K. Background pain in fibromyalgia patients affecting clinical examination of the skin. J Clin Nurs. 2002 Jan; 11(1): 58-64. ABSTRACT.
Rahm B., Lacour M., Decety J., Muller J., Scheidt C.E., Bauer J., Konig R., Wirshing M., Glauche V., Ohlendorf S., Unterbrink T., Hartmann A., Joos A.A. Self-perspective leads to increased activation of pain processing brain regions in fibromyalgia. Comprehensive Psychiatry. 2015; 59:80-90.
Rajagopal S., Deb I., Poddar R., Paul S. Aging is associated with dimerization and inactivation of the brain-enriched tyrosine phosphatase STEP. Neurobiology of Aging.41 (2016: 25-38.
Ramanathan S., Panksepp J., Johnson B. Is fibromyalgia an endocrine/endorphin deficit disorder? Is low dose naltrexone a new treatment option? Psychosomatics. 2012; 53:591-4.
Refetoff S., Dumitrescu A.M. Syndromes of reduced sensitivity to thyroid hormone: Genetic defects in hormone receptors, cell transporters, and deiodination. Best Pract & Res Clin Endocrinol & Metabol. 2007; 21(2):277-305.
Regland B., Forsmark S., Halaouate L., Matousek M., Peilot B., Zachrisson O., Gottfries C.G. Response to vitamin B12 and folic acid in myalgic encephalomyelitis and fibromyalgia. PLOS ONE. April 22, 2015.
Rice J.R. “Fibrositis” syndrome. Med Clin North Am. 1986 Mar;70(2): 455-68.
Riedel W., Layka H., Neeck G. Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones. Z. Rheumatol. 1998; 57(2): 81-87.
Rischmueller M., Tieu J., Lester S. Primary Sjogren’s syndrome. Best Practice & Res Clin Rheum. 2016; 30:189-230.
Riva R., Mork P.J., Westgaard R.H., Okkenhaug Johansen T., Lundberg U.Catecholamines and heart rate in female fibromyalgia patients. J Psychosom Res 2012 Jan; 72 (1): 51-7. Abstract.
Riva R., Mork P.J., Westgaard R.H., Ro M., Lundberg U. Fibromyalgia syndrome is associated with hypocortisolism. Int J Behav Med. 2010 Sep; 17(3): 223-33.
Rivera J., Vallejo M.A. Fibromyalgia is associated to recieving chronic medications behond appropriateness: A cross-sectional study. Rheumatol Int. 2016; 1691-9.
Robinson M.E., Craggs J.G., Price D.D., Peristein W.M., Staud R. Gray matter volumes of pain-related brain areas are decreased in fibromyalgia syndrome. J Pain. 2011 Apr; 12(4): 436-43. ABSTRACT.
Robinson R.L., Kroenke K., Mease P., Williams D.A., Chen Y., D’Souza D., Wohlreich M., McCarberg B. Burden of Illness and Treatment Patterns for Patients with Fibromyalgia. Pain Medicine. 2012; 13:1366-76.
Rodriguez A., Tembi J., Mesa-Gresa P., Munoz M.A., Montoya P., Rey B. Altered cerebral blood flow velocity features in fibromyalgia patients in resting-state conditions. PLOS ONE; https//doi.org/10.137/journal.pone.0180253. Accessed July 12, 2017.
Rodriguez-Espinosa J., Diaz-Lopez C., Guinot M., Geli C. de Llobet J.M., Rodriguez de la Serna A. Thyroid dysfunction in women with suspected fibromyalgia. Reumatol Clin. 2006 Mar: 2(2): 70-7. ABSTRACT.
Rodrigo L., Blanco I., Bobes J., de Serres F.J. Effect of one year of a gluten-free diet on the clinical evolution of irritable bowel syndrome plus fibromyalgia in patients wit associated lymphocytic enteritis: A case-control study. Arthritis Res Ther. 2014 Aug 27; 16(4): 421. ABSTRACT.
Romano G.E., Tomassi S., Russell A., Mondelli V., Pariante C.M. Fibromyalgia and chronic fatigue: The underlying biology and related theoretical issues. Adv Psychosom Med. 2015; 34: 61-77. ABSTRACT.
Rosborg I., Hyllen E., Lidbeck J., Nijlgard B., Gerhardsson L. Trace element pattern in patients with fibromyalgia. Sci Total Environ. 2007 Oct 15; 385(1-3): 20-7.
Rosenhall U., Johansson G., Orndahl G. Otoneurologic and audiologic findings in fibromyalgia. Scand J Rehabil Med. 1996 Dec; 23(4):225-32.
Rossello F., Munoz M.A., Duschek S., Montoya P. Affective modulations of brain and autonomic responses in patients with fibromyalgia. Psychosom Med. 2015 Sept; 77:721-32.
Rossi A., Di Lollo A.C., ,Guzzo M.P., Giacomelli C., Atzeni F., Bazzaichi L., Di Franco M. Fibromyalgia and nutrition: What news? Clin Exp Rheumatol. 2015 Jan-Feb; 33 (1 Suppl 88):S117-25. ABSTRACT.
Rudrud L. Gentle Hatha yoga and reduction of fibromyalgia-related symptoms: A preliminary report. Int J Yoga Therap. 2012; 22: 53-7. ABSTRACT.
Rus A., Molina F., Gasso M., Camacho M.V., Peinado M.A., Moral M.L. Nitric oxide, inflammation, lipid profile, and cortisol in normal- and overweight women with fibromyalgia. Biol Res Nurs. 2016 Mar; 18(2):138-46. Abstract.
Russek L., Gardner S., Maguire K., Stevens C., Brown E.Z., Jayawardana V., Mondal S. A cross-sectional survey assessing sources of movement-related fear among people with fibromyalgia syndrome. Clin Rheumatol. 2015; 34:1109-19.
Russell I.J., Larson A.A. Neurophysiopathogenesis of fibromyalgia syndrome: A unified hypothesis. Rheum Dis Clin North Am. 2009 May;35(2):421-35.
Russell I.J., Michalek J.E., Vipraio G.A., Fletcher E.M., Wall K. Serum amino acids in fibrositis/fibromyalgia syndrome. J Rheumatol Suppl. 1989 Nov;19:158-63. Abstract.
Sagar D.R., Burston J.J., Woodhams S.G., Chapman V. Dynamic changes to the endocannabinoid system in models of chronic pain. Phil Trans R Soc B. 2012; 367:3300-11.
Salkovskis P.M., Rimes K.A., Warwick H.M.C., Clark D.M. The Health Anxiety Inventory: Development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychological Medicine. 2002; 32: 843-53.
Sanada K., Diez M.A., Valero M.S., Perez-Yus M.C., Demarzo M.M.P., Garcia-Toro M., Garcia-Campayo J. Effects of non-pharmacological interventions on inflammatory biomarker expression in patients with fibromyalgia: A systematic review. Arthritis Res & Ther. 2015; 17:272-88.
Sanchez A., Calpena A.C., Clares B. Evaluating the oxidative stress in inflammation: Role of melatonin. Int J Mol Sci. 2015; 16: 16981-17004.
Sandberg M., Larsson B., Lindberg L.G., Gerdle B. Different patterns of blood flow response in the trapezius muscle following needle stimulation (acupuncture) between healthy subjects and patients with fibromyalgia and work-related trapezius myalgia. Eur J Pain. 2005 Oct; 9(5):497-510. ABSTRACT.
Santos D.De., Lage L.V., Jabur E.K., Kaziyama H.H., Iosifescu D.V., Lucia M.C., Fraguas R. The association of major depressive episode and personality traits in patients with fibromyalgia. Clinics. 2011;66(6): 973-8. ABSTRACT.
Sarifakioglu B., Guzelant A.Y., Guzel E. C., Guzel S., Kiziler A.R. Effects of 12-week combined exercise therapy on oxidative stress in female fibromyalgia patients. Rheumatol Int. 2014 Oct;34(10): 1361-7.
Sarzi-Puttini P., Atzeni F., Cazzola M. Neuroendocrine therapy of fibromyalgia syndrom: An update. Ann NY Acad Sci. 2010; 1193:91-7.
Sauer R.W., Hackel D., Morschel L., Sahlbach H., Wang Y., Mousa S.A., Roewer N., Brack A., Rittner H.L. Toll like receptor (TLR)-4 as a regulator of peripheral endogenous opioid-mediated analgesia in inflammation. Molecular Pain. 2014; 10:10.
Sawada F., Nomura Y., Goto F., Murakami M., Jike M., Toi T., Furusaka T., Ikeda M., Oshima T. Relationship of physical distress to dizziness in patients with fibromyalgia.Acta Oto-Laryngologica. 2016; 136(1): 56-61.
Schmechel D.E., Edwards C. Fibromyalgia, mood disorders, and intense creative energy: A1AR polymorphisms are not always silent. NeuroToxicology. 2012; 33:1454-1472.
Segura-Jimenez V., Carbonell-Baeza A., Aparicio V.A., Samos B., Femiz P., Ruiz J.R., Delgado-Fernandez M. A warm water pool-based exercise program decreases immediate pain in female fibromyalgia patients: Uncontrolled clinical trial. Int J Sports Med. 2013 Jul; 34(7): 600-5. ABSTRACT.
Severiano Ribeiro L., Proietti F.A. Interrelations between fibromyalgia, thyroid antibodies, and depression. J of Rheum. 2004; 31: 2036-40.
Shell W.E., Charuvastra E.H., DeWood M.A., May L.A., Bullias D.H., Silver D.S. A double-blind controlled trial of a single dose naproxen and an amino acid medical food theramine for the treatment of low back pain. Am J of Therapeutics. 2012; 19: 108-114.
Shell W.E., Pavlik S., Roth B., Silver M., Breitstein M.L., May L., Silver D. Reduction in pain and inflammation associated with chronic low back pain with the use of the medical food theramine. Am J of Therapeutics. 2014.
Shokouhi M., Davis K.D., Moulin D.E., Morley-Forster P., Nielson W.R., Bureau Y., St. Lawrence K. Basal ganglia perfusion in fibromyalgia is related to pain disability and disease impact: An arterial spin labeling study. Clin J. Pain. 2016; 32(6): 495-505.
Sil S., Thomas S., DiCesare C., Strotman D., Ting T.V., Myer G., Kashikar-Zuck S.Preliminary evidence of altered biomechanics in adolescents with juvenile fibromyalgia. Arthritis Care Res. 2015 Jan; 67(1): 102-11.
Skaer T.L. Fibromyalgia: Disease synopsis, medication cost effectiveness and economic burden. PharmacoEconomic. 2014; 32:457-66.
Slim M., Calandre E.P., RIco-Villademoros F. An insight into the gastrointestinal component of fibromyalgia: Clinical manifestations and potential underlying mechanisms. Rheumatol Int. 2015 Mar; 35(3): 433-44. ABSTRACT.
Slominski A.T., Zmijewski M.A., Skobowiat C., Zbytek B., Slominski R.M., Steketee J.D. Sensing the Environment: Regulation of local and global homeostasis by the skin’s neuroendocrine system. Adv Anat Embryol Cell Biol. 2012; 212: 1-115. ABSTRACT.
Sluka K.A., Clauw D.J. Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience. 2016; 338: 114-20.
Smith J.D., Terpening C.M., Schmidt S.O.F., Gums J.G. Relief of fibromyalgia symptoms following discontinuation of dietary excitotoxins. Annals Pharmaco. 2001 June; 35: 702-6.
Snider N.T., Walker V.J., Hollenberg P.F. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 Monooxygenases: Physiological and pharmacological implications. Pharmacol Rev. 2010; 62: 136-54.
Spitzer A.R., Broadman M. A retrospective review of the sleep characteristics in patients with chronic fatigue syndrome and fibromyalgia. Pain Practice. 2010; 10(4): 294-300.
Stahl S.M. Fibromyalgia – pathways and neurotransmitters. Hum Psychopharmacol Clin Exp. 2009; 24:S11-S17.
Staud R. Brain imaging in fibromyalgia syndrome. Clin Exp Rheumatol. 2011 Nov-Dec;29(6 Suppl 69): S109-17. ABSTRACT.
Staud R. Cytokine and immune system abnormalities in fibromyalgia and other central sensitivity syndromes. Curr Rheumatol Rev. 2015; 11(2): 109-15. ABSTRACT.
Staud R., Spaeth M. Psychophysical and neurochemical abnormalities of pain processing in fibromyalgia. CNS Spectr. 2008 Mar; 13 (3 Suppl 5): 12-7. ABSTRACT.
Steinberg C.L. Tocopherols in treatment of primary fibrositis including Dupuytren’s contracture, periarthritis of the shoulders, and Peyronie’s disease. AMA Arch Surg. 1951 Dec; 63(6): 824-33.
Stejskal V., Ockert K., Blorklund G. Metal-induced inflammation triggers fibromyalgia in metal-allergic patients. Neuro Endocrinol Lett. 2013; 34(6): 599-65. Abstract.
Stisl S., Cazzola M., Buskila D., et al. Etiopathogenetic mechanisms of fibromyalgia syndrome. Reumatismo. 2008. Jul-Sept;60 Suppl 1:25-35. Abstract.
Suk J.H., Lee J.H., Kim J.M. Association between thyroid autoimmunity and fibromyalgia. Exp Clin Endocrinol Diabetes. 2012 Jul; 120(7): 401-4. ABSTRACT.
Sussman E.S., Chen S., Sussman-Fort J., Dinces E. The five myths of MMN: Redefining how to use MMN in basic and clinical research. Brain Topogr. 2014 July; 27(4): 553-64.
Tak L.M., Cleare A.J., Ormel J., Manoharan A., Kok I.C., Wessely S., Rosmalen J.G.M. Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. Biolo Psychology. 2011; 87:183-94.
Tagoe C.E. Rheumatic symptoms in autoimmune thyroiditis. Curr Rheumatol Rep. 2015; 17:5.
Taylor A.G., Fischer-White T.G., Anderson J.G., Adelstein K.E., Murugesan M., Lewis J.E., Scott M.M., Gaykema R.P.A., Goehler L.E. Stress, inflammation and pain: A potential role for monocytes in fibromyalgia-related symptom severity. Stress and Health. 2015; 32: 503-13.
Taymur I., Ozdel K., Gundogdu I., Efe C., Tulaci R.G., Kervancioglu A. Personality-related core beliefs in patients diagnosed with fibromyalgia plus depression: A comparison with depressed and healthy control groups. Nord J Psychiatry 2015 Jul;69(5):386-91. ABSTRACT.
Tennant F. Hormone abnormalities in patients with severe and chronic pain who fail standard treatments. Postgrad Med. 2015; 127(1):1-4.
Tesher M.S. Juvenile fibromyalgia: A multidisciplinary approach to treatment. Pediatr Ann. 2015 Jun; 44(6): e136-41.
Theoharides T.C., Stewart J.M., Hatziagelaki E., Kolaitis G. Brain “fog,” inflammation and obesity: Key aspects of neuropsychiatric disorders improved by luteolin. Frontiers in Neurosci. 2015 July; 9.
Theoharides T.C., Tsilioni I., Arbetman L., Panagiotidou S., Stewart J.M., Gleason R.M., Russell I.J. Fibromyalgia syndrome in need of effective treatments. J Pharmocol Exp Ther. 2015 Nov; 355:255-63.
Tjorve E., Tjorve K.M.C., Olsen J.O., Senum R., Oftebro H. On commonness and rarity of thyroid hormone resistance: A discussion based on mechanisms of reduced sensitivity in peripheral tissues. Med Hypotheses. 2007; 69:913-21.
Torres X., Bailles E., Valdes M., Gutierrez F., Peri J.M., Arias A., Gomez E., Collado A.Personality does not distinguish people with fibromyalgia but identifies subgroups of patients. Gen Hosp Psychiatry. 2013; 35: 640-8.
Tovoli F., Giampaolo L., Caio G., Monti M., Piscaglia M., Frisoni M., Bolondi L., Volta U. Fibromyalgia and coeliac disease: A media hype or an emerging clinical problem? Clin Exp Rheumatol. 2013 Nov-Dec; 31(6 Suppl 79):S50-2
Tsai P.S., Fan Y.C., Huang C.J. Fibromyalgia is associated with coronary heart disease: A population-based cohort study. Reg Anesthesia and Pain Med. 2015 Jan/Feb; 40(1):37-42.
Tsilioni I., Russell I.J., Stewart J.M., GLeason R.M., Theoharides T.C. Neuropeptides CRH, SP, HI-1, and inflammatory cytokines IL-6 and TNF are increased in serum of patients with fibromyalgia syndrome, implicating mast cells. J Pharmacol Exp Ther. 2016 March; 356-64.
Udoji M.A., Ness T.J. New directions in the treatment of pelvic pain. Pain Manag. 2013 Sept; 3(5): 387-94.
Ugus F., Kucuk A., Cicek E., Kayhan F., Salli A., Guncu H., Cilli A.S. Quality of life in rheumatological patients: The impact of personality disorders. Int J Psychiatry Med. 2015;49(3):199-207. ABSTRACT.
Umeda M., Newcomb L.W., Koltyn K. Influence of Blood Pressure Elevations by Isometric Exercise on Pain Perception in Women. Int’l J of Psychophysiology. 74 (2009): 45-52.
Valim V., Natour J., Xiao Y., Pereira A.F., Lopes B.B., Pollack D.F., Zandonade E., Russell I.J. Effects of physical exercise on serum levels of serotonin and its metabolite in fibromyalgia: A randomized pilot study. Rev Bras Reumatol 2013 Nov-Dec;53(6):538-41. Abstract.
Van Houdenhove B., Kempke S. Psychiatric aspects of chronic fatigue syndrome and fibromyalgia. Curr Psychiatry Rep. 2010; 12:208-14.
Van Middendorp H., Kool M.B., van Beugen S., Denollet J., Lumley M.A., Geenen R.Prevalence and relevance of type D personality in fibromyalgia. Gen Hosp Psychiatry.2016; 39:66-72.
Van Ryckeghem D., Crombez G. General hypervigilance in fibromyalgia: One swallow does not make a summer. Eur J Pain. 2015; 19:447-8. Comment on Carrillo-de-la-Pena et al.
Vargas-Alarcon G., Alvarex-Leon E., Fragoso J.M., Vargas A., Martinez A., Vallejo M., Martinez-LavinM. A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia. BMC Musculoskelet Disord. 2012 Feb 20:13:23. ABSTRACT.
Vehof J., Smitt-Kamminga N.S., Kozareva D., Nibourg S.A., Hammon C.J. Clinical characteristics of dry eye patients with chronic pain syndromes. Am J Ophthalmol. 2016 Feb; 162: 59-64.
Vellisca M.Y., Latorre J.I. Monosodium glutamate and aspartame in perceived pain in fibromyalgia. Rheumatol Int. 2014 Jul; 34(7): 1011-3. ABSTRACT.
Vincent A., Whipple M.O., Rhudy L.M. Fibromyalgia flares: A qualitative analysis. Pain Medicine 2016; 17:463-8.
Vincent A., Whipple M.O., Low P.A., Joyner M., Hoskin T.L. Patients with fibromyalgia have significant autonomic symptoms but modest autonomic dysfunction. Physical Medicine and Rehabilitation. 2016; 8:425-35.
Viola-Saltzman M., Watson N.F., Bogart A., Goldberg J., Buchwald D. High prevalence of Restless Legs Syndrome among patients with fibromyalgia: A controlled cross-sectional study. J of Clin Sleep Med. 2010; 6(5): 423-7.
Vitali C., Del Papa N. Pain in primary Sjogren’s syndrome. Best Pract Res Clin Rheumatol. 2015; 29:63-70.
Vlainich R., Issy A.M., Sakata R.K. Effect of intravenous lidocaine associated with amitriptyline on pain relief and plasma serotonin, norepinephrine, and dopamine concentrations in fibromyalgia. Clin J Pain. 2011 May;27(4): 285-8.
Vogt B.A. Midcingulate cortex: Structure, connections, homologies, functions and diseases. J Chem Neuroanatomy. 2016;24: 28-46.
Volta U. Gluten-free diet in the management of patients with irritable vowel syndrome, fibromyalgia and lymphocytic enteritis. Arthritis Res Ther. 2014 Dec 23; 16(6): 505. ABSTRACT.
Vural M., Berkol T.D., Erdogdu Z., Kucukserat B., Aksoy C. Evaluation of personality profile in patients with fibromyalgia syndrome and healthy controls. Mod Rheumatol. 2014 Sep; 24(5):823-8. ABSTRACT.
Wahner-Roedler D.L., Elkin P.L., Vincent A., Thompson J.M., Oh T.H., Loehrer L.L., Mandrekar J.N., Bauer B.A. Use of Complementary and alternative medical therapies by patients referred to a fibromyalgia treatment program at a tertiary care center. Mayo Clin Proc. 2005 Jan; 80(1): 55-60.
Waldstein S.S. Thyroid-Catecholamine Interrelations. Annu Rev Med. 1966; 17:123-32.
Walitt B., Klose P., Uceyler N., Phillips T., Hauser W. Antipsychotics for fibromyalgia in adults. Cochrane Database Syst Rev. 2016 Jan; 6. Epub ahead of print. ABSTRACT.
Walter K.N., Corwin E.J., Ulbrecht J., Demers L.M., Bennett J.M., Whetzel C.A., Klein L.C. Elevated thyroid stimulating hormone is associated with elevated cortisol in healthy young men and women. Thyroid Res. 2012; 5:13.
Wang J., Garcia-Bailo B., Nielsen D.E., El-Sohemy A. ABO Genotype, ‘Blood-Type’ diet and cardiometabolic risk factors. Plos One. 2014 Jan; 9(1): e84749.
Watson N.F., Buchwald D., Goldberg J., Maravilla K.R., Noonan C., Guan Q., Ellenbogen R.G. Is Chiari I malformation associated with fibromyalgia? Neurosurgery, 2011 Feb; 68(2): 443-9.
Watson N.F., Buchwald D., Goldberg J., Noonan C., Ellenbogen R.G. Neurological signs and symptoms in fibromyalgia. Arthritis Rheum. 2009 Sep; 60(9):2839-44.
Waylonis G.W., Heck W. Fibromyalgia syndrome: New associations. Am J Phys Med & Rehabil. 1992; 71(6): 343-8.
Weiss R.E., Dumitrescu A., Refetoff S. Approach to the patient with resistance to thyroid hormone and pregnancy. J Clin Endocrinol Metab. 2010 Jul; 95(7): 3094-3102.
Wells A.F., Arnold L.M., Curtis C.E., Dunegan L.J., Lapp C.W., McCarberg B.H., Clair A.Integrating health information technology and electronic health records into the management of fibromyalgia. Postgrad Med. 2013 Jul; 125(4):70-7.
White H.D., Robinson T.D. A novel use for testosterone to treat central sensitization of chronic pain in fibromyalgia patients. International Immunopharm. 2015; 27:244-8.
Wilke W.S., Sheeler L.R., Makarowski W.S. Hypothyroidism with presenting symptoms of fibrositis. J Rheumatol. 1981 Jul-Aug; 8(4): 626-31. ABSTRACT.
William A. Epstein-Barr virus, chronic fatigue syndrome, and fibromyalgia. From the Medical Medium – and What’s Potentially at the Root of Medical Mysteries. http://goop.com. Accessed March 18, 2016.
Winarni T.K., Chonchalya W., Sumekar T.A., Ashwood P., Mendoza Morales G., Tassone F., Nguyen D.V., Faradz S.M.H., Van de Water J., Cook K., Hamlin A., Mu Y. Hagerman P.J., Hagerman R.J. Immune-mediated disorders among women carriers of fragile X permutation alleles. Am J of Med Gen. 2012.
Wolfe F., Walitt B.T., Rasker J.J., Katz R.S., Hauser W. The use of polysymptomative distress categories in the evaluation of fibromyalgia (FM) and FM severity. J Rheumatol. 2015 Aug; 42(8): 1494-1501.
Wood P.B. A reconsideration of the relevance of systemic low-dose ketamine to the pathophysiology of fibromyalgia. J Pain. 2006 Sep; 7(9):611-4.
Wood P.B. Variations in brain gray matter associated with chronic pain. Curr Rheumatol Rep. 2010 Dec; 12(6):462-9.
Wood P.B., Patterson J.C., Sunderland J.J., Tainter K.H., Glabus M.F., Lilien D.L. Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: A pilot study. J of Pain. 2007 Jan; 8(1): 51-8.
Yang B., Hong W., Wang Z., Liu Y., Xue Z., Li Y. Efficacy of acupuncture on fibromyalgia syndrome: A meta-analysis. J Tradit Cin Med. 2014 Aug; 34(4): 381-91.
Yoga Journal Editors. Is Yoga Cardio? Learn how to get fit with yoga. http://www.yogajournal.com/article/lifestyle/pump-it-up. Accessed December 6, 2016.
Yoga Styles. https://www.doyogawithme.com/types-of-yoga. Accessed October 31, 2016.
Zeidan F., Salamons T., Farris S.R., Emerson N.M., Adler-Neal A., Youngkoo J., Coghill R.C. Neural Mechanisms Supporting the Relationship between Dispositional Mindfulness and Pain. Pain. 2018 Dec; 159(12):2477-2485.
Zhang L., Zhu J., Chen Y., Zhao J. Meta-analysis reveals a lack of association between a common catechol-O-methyltransferase (COMT) polymorphism val (158) met and fibromyalgia. Int J Clin Exp Pathol. 2014 Dec 1; 7(12):8489-97. ABSTRACT.
Zimmerman-Belsing T., Brabant G., Holst J.J., Feldt-Rasmussen U. Circulating leptin and thyroid dysfunction. Eur J Endocrinology. 2003; 149:257-71.
Fibromy What? 